Shah Rutul R: insider trades.
Shah Rutul R reported 11 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($1.1M), across 1 company.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- Shah Rutul R
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Precigen, Inc. (PGEN) | Officer · Chief Operating Officer | 11 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-25 | Precigen, Inc. | M | 15,342 | $2.33 | 484,207 | Form 4 |
| 2026-08-25 | Precigen, Inc. | S | 15,342 | $7.5 | 468,865 | Form 4 |
| 2026-08-23 | Precigen, Inc. | M | 7,500 | — | 472,512 | Form 4 |
| 2026-08-23 | Precigen, Inc. | F | 3,647 | $7.2 | 468,865 | Form 4 |
| 2026-08-21 | Precigen, Inc. | M | 34,658 | $2.33 | 499,670 | Form 4 |
| 2026-08-21 | Precigen, Inc. | S | 34,658 | $7.5 | 465,012 | Form 4 |
| 2026-08-06 | Precigen, Inc. | S | 32,739 | $6.86 | 465,012 | Form 4 |
| 2026-08-03 | Precigen, Inc. | S | 33,772 | $6.5 | 497,751 | Form 4 |
| 2026-08-03 | Precigen, Inc. | M | 33,772 | $2.33 | 531,523 | Form 4 |
| 2026-06-29 | Precigen, Inc. | M | 42,924 | $2.33 | 540,675 | Form 4 |
| 2026-06-29 | Precigen, Inc. | S | 42,924 | $5.85 | 497,751 | Form 4 |
Questions
What stock did Shah Rutul R buy or sell?
Shah Rutul R reported 11 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($1.1M), across 1 company.
Is Shah Rutul R the same person as other filers with this name?
This page covers SEC CIK 1947221 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/shah-rutul-r-1947221.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.